These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38738764)

  • 1. Validation of a Primary Biliary Cholangitis-Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBC.
    Younossi ZM; Stepanova M; Younossi I; Racila A
    Clin Transl Gastroenterol; 2024 Sep; 15(9):e1. PubMed ID: 38738764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the chronic liver disease questionnaire in Serbian patients.
    Popovic DDj; Kovacevic NV; Kisic Tepavcevic DB; Trajkovic GZ; Alempijevic TM; Spuran MM; Krstic MN; Jesic RS; Younossi ZM; Pekmezovic TD
    World J Gastroenterol; 2013 Aug; 19(30):4950-7. PubMed ID: 23946600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Younossi ZM; Stepanova M; Younossi I; Racila A
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2093-2100.e3. PubMed ID: 30639779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC.
    Younossi ZM; Stepanova M; Younossi I; Racila A
    Hepatol Commun; 2023 Feb; 7(2):e0049. PubMed ID: 36724122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV.
    Younossi ZM; Stepanova M; Younossi I; Racila A
    J Viral Hepat; 2021 Mar; 28(3):484-492. PubMed ID: 33306234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO.
    Younossi ZM; Afendy A; Stepanova M; Racila A; Nader F; Gomel R; Safer R; Lenderking WR; Skalicky A; Kleinman L; Myers RP; Subramanian GM; McHutchison JG; Levy C; Bowlus CL; Kowdley K; Muir AJ
    Hepatology; 2018 Jul; 68(1):155-165. PubMed ID: 29152767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD.
    Younossi ZM; Stepanova M; Henry L; Racila A; Lam B; Pham HT; Hunt S
    Liver Int; 2017 Aug; 37(8):1209-1218. PubMed ID: 28211165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation, adaptation and validation of two versions of the Chronic Liver Disease Questionnaire in Malaysian patients for speakers of both English and Malay languages: a cross-sectional study.
    Khairullah S; Mahadeva S
    BMJ Open; 2017 May; 7(5):e013873. PubMed ID: 28550020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of health related quality of life in polish patients with primary biliary cirrhosis.
    Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Kostrzewa K; Norman GL; Bogdanos DP; Milkiewicz P
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):471-9. PubMed ID: 26621536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement properties of the PBC-40 and PBC-27: a Dutch validation study.
    de Veer RC; da Silva G; van Hooff MC; Harms MH; Metselaar HJ; Willemse J; Utomo E; van der Meer AJ
    BMJ Open Gastroenterol; 2021 Dec; 8(1):. PubMed ID: 34916226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic liver disease questionnaire: translation and validation in Thais.
    Sobhonslidsuk A; Silpakit C; Kongsakon R; Satitpornkul P; Sripetch C
    World J Gastroenterol; 2004 Jul; 10(13):1954-7. PubMed ID: 15222044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.
    Stanca CM; Bach N; Krause C; Tandon N; Freni MA; Gutierrez JA; Bodian C; Lopez J; Berk PD; Bodenheimer HC; Branch AD; Odin JA
    Am J Gastroenterol; 2005 May; 100(5):1104-9. PubMed ID: 15842585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.
    Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Bogdanos D; Milkiewicz P
    Liver Int; 2015 Jun; 35(6):1764-71. PubMed ID: 25388280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial.
    von Maltzahn R; Mayo MJ; Smith HT; Thompson A; Das S; de Souza AR; Lisi E; Levy C; McLaughlin MM; Jones D
    J Patient Rep Outcomes; 2024 Jun; 8(1):60. PubMed ID: 38862718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation and validation of the Hindi version of chronic liver disease questionnaire (CLDQ) for the assessment of health related quality of life in patient with chronic liver disease in India.
    Benjamin J; Mani K; Saraya A; Joshi YK
    Trop Gastroenterol; 2016; 37(2):112-22. PubMed ID: 30234280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of the chronic liver disease questionnaire for the Chinese population in Singapore.
    Chang PE; Tan HK; Lee Y; Fook-Chong S; Chia PY; Shaik-Hussain N; Lee HL; Aloweni F
    JGH Open; 2020 Apr; 4(2):191-197. PubMed ID: 32280764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.
    Jacoby A; Rannard A; Buck D; Bhala N; Newton JL; James OF; Jones DE
    Gut; 2005 Nov; 54(11):1622-9. PubMed ID: 15961522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis.
    Alrubaiy L; Mells G; Flack S; Bosomworth H; Hutchings H; Williams J; Jones D;
    Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1223-1231. PubMed ID: 31664722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.
    Kremer AE; Mayo MJ; Hirschfield G; Levy C; Bowlus CL; Jones DE; Steinberg A; McWherter CA; Choi YJ
    Liver Int; 2022 Jan; 42(1):112-123. PubMed ID: 34403559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language.
    Goel A; Arivazhagan K; Sasi A; Shanmugam V; Koshi S; Pottakkat B; Lakshmi CP; Awasthi A
    Indian J Gastroenterol; 2017 May; 36(3):217-226. PubMed ID: 28608324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.